R. Loch Macdonald
CIK 1653008 · Chief Medical Officer · last filed 2025-04-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$28.62M
Companies
4
Total Filings
13
Lifetime Open-Market Net
-$380.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GRCE | Chief Medical Officer | — | $2.20 | — | $0 | 1 | 2025-04-16 |
| Grace Therapeutics, Inc. (ACST) Delisted | Chief Medical Officer | — | $3.37 | — | $0 | 2 | 2024-05-08 |
| PDSB | Director | 587,729 | $1.05 | $617.1K | $0 | 1 | 2019-03-18 |
| EDGE | Chief Scientific Officer | 570,602 | $49.07 | $28.00M | -$380.4K | 9 | 2018-08-15 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-01-25 | EDGE | Exer (M) | +25,000 | $51.0K | EDGAR |
| 2016-02-18 | EDGE | Grant (A) | — | $0 | EDGAR |
| 2015-10-08 | EDGE | Mixed | +22,396 | $1.5K | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.